IC bioGUNE (Center for Cooperative Research in Biosciences), a non-profit
biomedical research organization, was inaugurated at the Technology Park of Bizkaia in
2005. CIC bioGUNE plays a strong role in advancing biomedical research and
technological innovation in the Basque Country. CIC bioGUNE provides state-of-the-art
research infrastructure in genomics, proteomics, metabolomics and structural biology
facilities, among others. It employs 22 research group leaders, more than 85 postdocs,
technicians and engineers, and provides training opportunities to over twenty PhD
students each year. International recruitment, includes fellows from Ikerbasque,
Bizkaia:talent, and Ramón y Cajal programs. CIC bioGUNE receives competitive
research grants (European Union, NIH, and the Spanish Plan Nacional I+D+I, FIS,
CIBER and CONSOLIDER programs, BBVA Foundation and Genome Spain).
Rosa Barrio started her work on ubiquitin-like genes during her PhD at the Center of Molecular Biology Severo Ochoa (Madrid, Spain), where she characterized the ubiquitin genes in Drosophila. She continued with her studies at Harvard University-USA, IMBB-Greece, EMBL-Germany, CBMSO-Spain. She is currently Principal Investigator at the Functional Genomics Unit of CIC bioGUNE. Rosa Barrio coordinated two European projects, one of them dedicated to the training of early stage researchers (ITN program, UPStream); the other grant being a large consortium of European groups interested in the field of the ubiquitin-likes (COST, PROTEOSTASIS).